错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Research progress of propofol in alleviating cerebral ischemia/reperfusion injury

  • Haijing Zheng,
  • Xian Xiao,
  • Yiming Han,
  • Pengwei Wang,
  • Lili Zang,
  • Lilin Wang,
  • Yinuo Zhao,
  • Peijie Shi,
  • Pengfei Yang,
  • Chao Guo,
  • Jintao Xue,
  • Xinghua Zhao

摘要

Ischemic stroke is a leading cause of adult disability and death worldwide. The primary treatment for cerebral ischemia patients is to restore blood supply to the ischemic region as quickly as possible. However, in most cases, more severe tissue damage occurs, which is known as cerebral ischemia/reperfusion (I/R) injury. The pathological mechanisms of brain I/R injury include mitochondrial dysfunction, oxidative stress, excitotoxicity, calcium overload, neuroinflammation, programmed cell death and others. Propofol (2,6-diisopropylphenol), a short-acting intravenous anesthetic, possesses not only sedative and hypnotic effects but also immunomodulatory and neuroprotective effects. Numerous studies have reported the protective properties of propofol during brain I/R injury. In this review, we summarize the potential protective mechanisms of propofol to provide insights for its better clinical application in alleviating cerebral I/R injury.